×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Contact Us
About Us
Subscribe
My Portfolio
My Account
Contact Us
About Us
Subscribe
My Account
My Portfolio
Logo

Insider Transactions by Adam Dubow

Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
DAWNDay One Biopharmaceuticals, Inc.Adam DubowGen Counsel & SecretaryAug 15, 2025Option/RSU Exercise-12,087-59,223Aug 19, 2025, 07:38 PM
DAWNDay One Biopharmaceuticals, Inc.Adam DubowGen Counsel & SecretaryAug 18, 2025Sale$6.774,36529,53854,858Aug 19, 2025, 07:38 PM
DAWNDay One Biopharmaceuticals, Inc.Adam DubowGENERAL COUNSELMay 15, 2025Option/RSU Exercise-12,086-51,688May 19, 2025, 05:48 PM
DAWNDay One Biopharmaceuticals, Inc.Adam DubowGENERAL COUNSELMay 16, 2025Sale$6.264,55228,48647,136May 19, 2025, 05:48 PM
DAWNDay One Biopharmaceuticals, Inc.Adam DubowGENERAL COUNSELFeb 15, 2025Option/RSU Exercise-12,086-44,248Feb 21, 2025, 06:08 PM
DAWNDay One Biopharmaceuticals, Inc.Adam DubowGENERAL COUNSELFeb 18, 2025Sale$11.964,64655,58039,602Feb 21, 2025, 06:08 PM
DAWNDay One Biopharmaceuticals, Inc.Adam DubowGENERAL COUNSELNov 15, 2024Option/RSU Exercise-8,399-35,327Nov 19, 2024, 04:32 PM
DAWNDay One Biopharmaceuticals, Inc.Adam DubowGENERAL COUNSELNov 18, 2024Sale$13.213,16541,81032,162Nov 19, 2024, 04:32 PM
DAWNDay One Biopharmaceuticals, Inc.Adam DubowGENERAL COUNSELAug 15, 2024Option/RSU Exercise-8,399-30,130Aug 19, 2024, 06:12 PM
DAWNDay One Biopharmaceuticals, Inc.Adam DubowGENERAL COUNSELAug 16, 2024Sale$14.003,20244,82526,928Aug 19, 2024, 06:12 PM
DAWNDay One Biopharmaceuticals, Inc.Adam DubowGENERAL COUNSELMay 16, 2024Sale$16.083,25352,30421,731May 17, 2024, 06:11 PM
DAWNDay One Biopharmaceuticals, Inc.Adam DubowGENERAL COUNSELMay 15, 2024Option/RSU Exercise-8,399-24,984May 17, 2024, 06:11 PM
DAWNDay One Biopharmaceuticals, Inc.Adam DubowGENERAL COUNSELFeb 15, 2024Option/RSU Exercise-8,399-19,827Feb 20, 2024, 06:48 PM
DAWNDay One Biopharmaceuticals, Inc.Adam DubowGENERAL COUNSELFeb 16, 2024Sale$15.253,24249,43416,585Feb 20, 2024, 06:48 PM
DAWNDay One Biopharmaceuticals, Inc.Adam DubowGeneral CounselNov 15, 2023Option/RSU Exercise-13,600-16,741Nov 17, 2023, 06:30 PM
DAWNDay One Biopharmaceuticals, Inc.Adam DubowGeneral CounselNov 16, 2023Sale$11.695,31362,10911,428Nov 17, 2023, 06:30 PM
BMYBRISTOL MYERS SQUIBB COAdam DubowSVP,ChiefCompliance&EthicsOff.Jul 30, 2021Sale$67.902,466167,44113,777Aug 03, 2021, 04:56 PM
BMYBRISTOL MYERS SQUIBB COAdam DubowSVP,ChiefCompliance&EthicsOff.Mar 10, 2021Tax Payment (Shares)$60.931,910116,37619,362Mar 12, 2021, 06:59 PM
BMYBRISTOL MYERS SQUIBB COAdam DubowSVP,ChiefCompliance&EthicsOff.Mar 10, 2021Option/RSU Exercise-5,404-19,811Mar 12, 2021, 06:59 PM
BMYBRISTOL MYERS SQUIBB COAdam DubowSVP,ChiefCompliance&EthicsOff.Nov 24, 2020Sale$63.3990057,05115,186Nov 25, 2020, 04:32 PM
BMYBRISTOL MYERS SQUIBB COAdam DubowSVP,ChiefCompliance&EthicsOff.May 22, 2020Sale$61.013,200195,23216,086May 26, 2020, 05:17 PM
BMYBRISTOL MYERS SQUIBB COAdam DubowSVP,ChiefCompliance&EthicsOff.Mar 10, 2020Option/RSU Exercise-5,007-20,091Mar 12, 2020, 06:12 PM
BMYBRISTOL MYERS SQUIBB COAdam DubowSVP,ChiefCompliance&EthicsOff.Mar 10, 2020Tax Payment (Shares)$57.932,005116,15019,286Mar 12, 2020, 06:12 PM
BMYBRISTOL MYERS SQUIBB COAdam DubowChief Compliance & Ethics OffiDec 05, 2019Sale$58.811,740102,32915,749Dec 09, 2019, 04:44 PM
BMYBRISTOL MYERS SQUIBB COAdam DubowChief Compliance & Ethics OffiMar 10, 2019Tax Payment (Shares)$51.391,18260,74317,489Mar 13, 2019, 07:41 AM
BMYBRISTOL MYERS SQUIBB COAdam DubowChief Compliance & Ethics OffiMar 10, 2019Option/RSU Exercise-3,735-18,240Mar 13, 2019, 07:41 AM
BMYBRISTOL MYERS SQUIBB COAdam DubowChief Compliance & Ethics OffiSep 03, 2018Option/RSU Exercise-797-15,495Sep 05, 2018, 04:49 PM
BMYBRISTOL MYERS SQUIBB COAdam DubowChief Compliance & Ethics OffiSep 03, 2018Tax Payment (Shares)$60.5527316,53015,222Sep 05, 2018, 04:49 PM

Looking for more premium content?

We have created a comprehensive group of tools that allows you to estimate the intrinsic value of investments.

Subscribe